| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-03-30 | Shannon James Samuel Director | Purchase | +5,000 | +100.00%10,000 | $8.79 | $43,950 | View SEC filing | |
| 2026-02-17 | GILEAD SCIENCES, INC. 10% Owner | Purchase | +3,739,000 | +10.20%40,384,266 | $0.53 | $1,999,991 | View SEC filing | |
| 2026-01-05 | Brennan Kevin M. SVP, FINANCE AND ACCOUNTING | Sale | -1,826 | -22.28%6,371 | $0.64 | $1,174 | View SEC filing | |
| 2026-01-05 | Frankenfield Christopher James Chief Financial Officer | Sale | -7,030 | -22.11%24,766 | $0.64 | $4,522 | View SEC filing | |
| 2025-06-18 | Shannon James Samuel Director | Purchase | +70,000 | +100.00%70,000 | $0.69 | $48,085 | View SEC filing | |
| 2025-06-18 | Russo Rene PRESIDENT AND CEO | Purchase | +36,289 | +14.82%281,172 | $0.68 | $24,680 | View SEC filing | |
| 2025-06-06 | GILEAD SCIENCES, INC. 10% Owner | Purchase | +53,340,000 | +534.72%63,315,266 | N/A | N/A | View SEC filing | |
| 2025-01-03 | Frankenfield Christopher James Chief Financial Officer | Sale | -6,954 | -35.89%12,421 | $0.98 | $6,841 | View SEC filing | |
| 2025-01-03 | Brennan Kevin M. SVP, FINANCE AND ACCOUNTING | Sale | -1,803 | -36.06%3,197 | $0.98 | $1,774 | View SEC filing | |
| 2024-12-19 | GILEAD SCIENCES, INC. 10% Owner | Purchase | +7,852,794 | +69.94%19,080,717 | $1.04 | $8,166,296 | View SEC filing | |
| 2024-04-03 | GILEAD SCIENCES, INC. 10% Owner | Purchase | +4,367,700 | +63.67%11,227,923 | $0.76 | $3,319,064 | View SEC filing | |
| 2024-02-09 | Atlas Venture Fund XI, L.P. 10% Owner | Sale | -1,000 | -0.04%2,754,109 | $0.64 | $640 | View SEC filing | |
| 2024-01-16 | Atlas Venture Fund XI, L.P. 10% Owner | Sale | -4,235 | -0.15%2,755,109 | $0.85 | $3,600 | View SEC filing | |
| 2021-12-10 | BCIP Life Sciences Associates, LP 10% Owner | Purchase | +42,469 | +1.54%2,805,413 | $9.66 | $410,161 | View SEC filing | |
| 2021-11-03 | SV7 Impact Medicine Fund LP 10% Owner | Purchase | +625,000 | +24.02%3,227,264 | $16.00 | $10,000,000 | View SEC filing | |
| 2021-10-28 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 10% Owner, Other | Purchase | +775,000 | +51.22%2,287,944 | $16.00 | $12,400,000 | View SEC filing | |
| 2021-10-26 | Rock Springs Capital Management LP 10% Owner | Purchase | +500,000 | +66.10%1,256,472 | $16.00 | $8,000,000 | View SEC filing | |
| 2021-10-26 | BAY CITY CAPITAL LLC 10% Owner | Purchase | +312,500 | +38.25%1,129,490 | $16.00 | $5,000,000 | View SEC filing | |
| 2021-10-26 | Atlas Venture Fund XI, L.P. 10% Owner | Purchase | +187,500 | +34.19%735,942 | $16.00 | $3,000,000 | View SEC filing | |
| 2021-10-26 | RiverVest Venture Fund IV, L.P. 10% Owner | Purchase | +250,000 | +20.98%1,441,444 | $16.00 | $4,000,000 | View SEC filing |
1-20 of 20
